Evidence map›Paper›PMID 35035585›Full record

ReviewDer Gastroenterologe : Zeitschrift fur Gastroenterologie und Hepatologie2022

[COVID-19 and endoscopy services].

S Hollerbach, C Römmele, A Muzalyova, H Messmann

Abstract readEnglish AbstractReview
In one paragraph

Review in Der Gastroenterologe : Zeitschrift fur Gastroenterologie und Hepatologie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

S HollerbachKlinik für Gastroenterologie/Endoskopie, Allgemeines Krankenhaus Celle (AKH), Siemensplatz 4, 29223 Celle, Deutschland.
C RömmeleIII. Medizinische Klinik, Univ.-Klinikum Augsburg, Augsburg, Deutschland.
A MuzalyovaIII. Medizinische Klinik, Univ.-Klinikum Augsburg, Augsburg, Deutschland.
H MessmannIII. Medizinische Klinik, Univ.-Klinikum Augsburg, Augsburg, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In 2020, the coronavirus pandemic initially led to a significant decrease in elective endoscopic examinations in Germany. The main reasons for this were the hard lockdown and the lack of personal protective equipment (PPE) and testing procedures. Since then, international recommendations from professional societies on infection control in endoscopy have been published. The extent to which these have been implemented in Germany is unclear: during the 2nd and 3rd waves in 2020/2021, most endoscopy units remained open and the level of adherence to international protection guidelines was high. A uniform "standard procedure" has not yet been published. The exact role and effectiveness of testing procedures to protect patients and staff during endoscopy was unknown, and reliable figures on staff and patient infections acquired/transmitted in endoscopy units in Germany were lacking. Thus, the most important finding of this work is the determined rate of coronavirus disease 2019 (COVID-19) in endoscopy facilities. The data show that the infection rate among staff in German clinics and practices in early 2021 averaged up to 5%; most of these were acquired in the private setting. Clinics with gastroenterological endoscopy units had significantly higher infection rates (10%) than, for example, dental and otolaryngology practices. This result indicates the need for continued PPE efforts. The most important factors for infection safety are fully vaccinated (or recovered) staff and patients, a decreasing prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the use of PPE and-although controversial-the consistent use of screening tests.

Indexed as

InfectionsSafetySARS-CoV‑2ScreeningStandards

Identifiers

PMID35035585
PMCPMC8749920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.